Among them, five samples displayed genomic imbalances typically associated with the CRC canonical pathway, including a focal amplification of MYC, unveiling tumors with co-occurrence of MSI and extensive genomic alterations (Trautmann et al., 2006). Here, MYC is linked to colorectal carcinoma.